Table 4. Kaplan-Meier survival table of the RFS and OS of the AML patients with FLT3/ITDs.
| Patient No. | CR rate (Months) | RFS (Months) |
Survival probability for RFS | Standard Error of RFS | 95% CI for RFS | OS (Months) |
Survival probability for OS | Standard Error of OS | 95% CI for OS | Cause of death | FAB subtype |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AML1 | No treatment | NA* | 0.4 | Alive | M4 | ||||||
| AML2 | No treatment | NA | 0.8 | 0.909 | 0.087 | 0.754-1 | Prior MDS | ||||
| AML3 | 1.0 | 6.2 | 0.635 | 0.169 | 0.238-0.866 | 13.9 | 0.487 | 0.188 | 0.228-1 | Relapse | M5a |
| AML4 | 1.3 | 15.9 | 0.000 | NA | NA | 24.6 | 0.325 | 0.183 | 0.108-0.978 | Relapse | M1 |
| AML5 | 1.8 | 8.6 | 10.5 | 0.649 | 0.167 | 0.392-1 | TransplantAlloSCT | M1 | |||
| AML6 | 1.2 | 10.8 | 12.1 | Alive | M1 | ||||||
| AML7 | 1.0 | 14.9 | 0.317 | 0.240 | 0.015-0.729 | 31.3 | Alive | M1 | |||
| AML8 | 1.6 | 7.1 | 8.7 | Alive | M3 | ||||||
| AML9 | NA | NA | 26.1 | 0.162 | 0.147 | 0.028-0.954 | Induction failure | M2 | |||
| AML10 | 2.1 | 3.4 | 0.889 | 0.105 | 0.433-0.984 | 5.6 | Alive | M1 | |||
| AML11 | 1.1 | 5.6 | 6.6 | Alive | M3 | ||||||
| AML12 | 2.3 | 5.8 | 0.762 | 0.148 | 0.332- 0.935 | 9.5 | 0.779 | 0.141 | 0.546-1 | Relapse | M1 |
* NA = not applicable